Pharmazz, Inc., located at 50 W 75th St STE 105 in Willowbrook, Illinois, operates as a leading pharmaceutical company focused on critical care medicine. This innovative biopharmaceutical firm boasts an approved product and a promising drug pipeline, backed by a seasoned management team. Pharmazz, Inc. is dedicated to discovering, acquiring, developing, and commercializing therapeutics that address urgent medical needs.
The company has made significant strides in the pharmaceutical industry, particularly with its majority-owned subsidiary, Pharmazz India Private Limited. This subsidiary successfully obtained marketing authorization for Lyfaquin® (INN: Centhaquine) in India, showcasing the company's commitment to expanding its reach and impact in global markets. Pharmazz, Inc. emphasizes research and development, ensuring that its products meet the highest standards of quality and efficacy.
With a focus on critical care medicine, Pharmazz, Inc. aims to provide solutions that improve patient outcomes and enhance the quality of life. The company's innovative approach and dedication to addressing unmet medical needs position it as a key player in the biopharmaceutical sector. Pharmazz, Inc. continues to strive for excellence in its product offerings and business practices.
Pharmazz, Inc. offers a range of services centered around drug development and commercialization in critical care medicine. Its achievements in gaining marketing authorization and its strong management team highlight its strengths in the pharmaceutical industry. Reach out to Pharmazz, Inc. in Willowbrook, Illinois, for more information on their innovative solutions.
